EMPA is driving the future of the global pharmaceutical industry by fostering member collaboration and information sharing.

EMPA’s core goal is to jointly address the diverse challenges faced by pharmaceutical companies, particularly in emerging markets, and to ensure global standards of quality and safety.

Over the past 20 years, Korea has achieved world-class advancements in pharmaceutical manufacturing technology, quality control, and GMP systems. Building on these achievements, EMPA aims to establish a platform that fosters practical cooperation and support among pharmaceutical companies worldwide, enabling them to share knowledge and experience across the global pharmaceutical network.